Trials / Completed
CompletedNCT01740817
A Study to Evaluate the Effect of Lipid Infusion on Toll Like Receptor 4 (TLR4) Signaling
A Randomized, Crossover Study to Evaluate the Effect of Lipid Infusion on TLR4 Signaling and Insulin Resistance in Human Muscle
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- The University of Texas Health Science Center at San Antonio · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether a lipid infusion can up-regulate toll-like receptor 4 (TLR4) signaling in human subjects
Detailed description
The investigators plan to examine the effect of a lipid infusion on TLR4 expression and insulin sensitivity. A group of 30 subjects aged 18-60 years old, lean (BMI \< 26 kg/m2) normal glucose tolerant subjects without a family history of type 2 diabetes will receive a lipid or saline infusion. The subjects will be randomly assigned to first receive either a 48 hour long lipid or saline infusion. Approximately 4-6 weeks later subjects will return to undergo another study (if, in the first study they received lipid, on the second study they will receive saline, and vice versa). A near-equal number of women and men will be included in each group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intralipid 20% | 30 ml/h for 48 h |
| DRUG | Saline | 30 ml/h for 48 h |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2013-12-01
- Completion
- 2015-09-01
- First posted
- 2012-12-04
- Last updated
- 2016-01-25
- Results posted
- 2016-01-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01740817. Inclusion in this directory is not an endorsement.